Gastrointestinal side effects are most common during dose escalation and may improve with slower titration or temporary interruption of treatment
paracetamol, cough syrups, antacids) - Easier to access & widely used for self-care - Lower margins compared to prescription drugs, but huge market volume Indias OTC Market: - Indias OTC segment is growing steadily with rising self-care awareness - Popular categories: pain relief, digestive health, vitamins & supplements - Big opportunity as lifestyle-related issues increase demand for wellness products Key Takeaway: - Prescription drugs drive innovation & profits
Biopolymers 97 , 678686 (2012)
The parenteral route remains dominant in the market due to the bioavailability challenges of peptide-based therapies
Microdosing Tirzepatide offers a more personalized approach with lower doses and steady clinical support
These include ready-to-eat food and drinks as well as powders and protein shakes that are dietary alternatives to conventional meals but in an easy-to-absorb form. GLP-1 Support Systems A 2024 report from Circana titled Tapping Into the Global Consumer Well-Being Opportunity, noted that sales of GLP-1 medicines are expected to reach $133 billion worldwide by 2030
